SG11202003147XA - Periodontitis vaccine and related compositions and method of use - Google Patents

Periodontitis vaccine and related compositions and method of use

Info

Publication number
SG11202003147XA
SG11202003147XA SG11202003147XA SG11202003147XA SG11202003147XA SG 11202003147X A SG11202003147X A SG 11202003147XA SG 11202003147X A SG11202003147X A SG 11202003147XA SG 11202003147X A SG11202003147X A SG 11202003147XA SG 11202003147X A SG11202003147X A SG 11202003147XA
Authority
SG
Singapore
Prior art keywords
related compositions
periodontitis
vaccine
periodontitis vaccine
compositions
Prior art date
Application number
SG11202003147XA
Inventor
Jeffery Fairman
Original Assignee
Vaxcyte Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vaxcyte Inc filed Critical Vaxcyte Inc
Publication of SG11202003147XA publication Critical patent/SG11202003147XA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/0216Bacteriodetes, e.g. Bacteroides, Ornithobacter, Porphyromonas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541Mucosal route
    • A61K2039/542Mucosal route oral/gastrointestinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541Mucosal route
    • A61K2039/543Mucosal route intranasal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55572Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
SG11202003147XA 2017-10-12 2018-10-11 Periodontitis vaccine and related compositions and method of use SG11202003147XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762571582P 2017-10-12 2017-10-12
PCT/US2018/055496 WO2019075260A1 (en) 2017-10-12 2018-10-11 Periodontitis vaccine and related compositions and method of use

Publications (1)

Publication Number Publication Date
SG11202003147XA true SG11202003147XA (en) 2020-05-28

Family

ID=64110091

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202003147XA SG11202003147XA (en) 2017-10-12 2018-10-11 Periodontitis vaccine and related compositions and method of use

Country Status (14)

Country Link
US (2) US10835590B2 (en)
EP (1) EP3694547A1 (en)
JP (2) JP7258870B2 (en)
KR (2) KR20230066660A (en)
CN (1) CN111225684A (en)
AU (1) AU2018347511A1 (en)
CA (1) CA3078630A1 (en)
EA (1) EA202090908A1 (en)
IL (1) IL273690A (en)
MA (1) MA50363A (en)
MX (1) MX2020003810A (en)
PH (1) PH12020550239A1 (en)
SG (1) SG11202003147XA (en)
WO (1) WO2019075260A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019075260A1 (en) 2017-10-12 2019-04-18 Sutrovax, Inc. Periodontitis vaccine and related compositions and method of use
CN116751292B (en) * 2023-07-31 2024-05-14 河南大学 Porphyromonas gingivalis Mfa monoclonal antibody and application thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59128338A (en) 1982-12-08 1984-07-24 Kitasato Inst:The Vaccine for preventing periodontitis
ATE182336T1 (en) 1993-05-28 1999-08-15 Chiron Corp PEPTIDE INHIBITORS OF UROKINASE RECEPTOR ACTIVITY
AUPN627595A0 (en) * 1995-10-30 1995-11-23 University Of Melbourne, The Diagnostics and treatments of periodontal disease
JP2000507245A (en) * 1996-03-22 2000-06-13 ユニバーシティー オブ ジョージア リサーチ ファウンデーション,インコーポレイテッド Immunogenic compositions and methods comprising Porphyromonas gingivalis peptides
US6833262B1 (en) 1999-04-21 2004-12-21 University Of Georgia Research Foundation, Inc. Polypeptide having amidolytic activity for a serpin
AUPQ065299A0 (en) 1999-05-28 1999-06-24 University Of Sydney, The A method of prophylaxis and treatment and agents useful for same
AUPQ485999A0 (en) * 1999-12-24 2000-02-03 Csl Limited P. gingivalis antigenic composition
US7378101B2 (en) 2001-12-21 2008-05-27 Pfizer, Inc. Vaccine for periodontal disease
GB0411150D0 (en) 2004-05-19 2004-06-23 Queen Mary & Westfield College Vaccine
US9366673B2 (en) 2009-08-02 2016-06-14 Sanofi Pasteur Limited Porphyromonas gingivalis polypeptides
WO2011097688A1 (en) 2010-02-12 2011-08-18 The University Of Sydney Protein domains and uses therefor
WO2011130544A2 (en) 2010-04-14 2011-10-20 Sutro Biopharma, Inc. Monitoring a dynamic system by liquid chromatography-mass spectrometry
KR102018863B1 (en) 2012-10-12 2019-09-05 서트로 바이오파마, 인크. Proteolytic inactivation of select proteins in bacterial extracts for improved expression
EP3365027B1 (en) * 2015-10-14 2022-03-30 Research Institute at Nationwide Children's Hospital Hu specific antibodies and their use in inhibiting biofilm
WO2019075260A1 (en) 2017-10-12 2019-04-18 Sutrovax, Inc. Periodontitis vaccine and related compositions and method of use

Also Published As

Publication number Publication date
MA50363A (en) 2020-08-19
AU2018347511A1 (en) 2020-05-21
US20210361756A1 (en) 2021-11-25
CA3078630A1 (en) 2019-04-18
EA202090908A1 (en) 2020-10-29
KR20200070302A (en) 2020-06-17
MX2020003810A (en) 2020-08-13
KR20230066660A (en) 2023-05-16
JP2023098935A (en) 2023-07-11
US11701414B2 (en) 2023-07-18
IL273690A (en) 2020-05-31
EP3694547A1 (en) 2020-08-19
US20190192645A1 (en) 2019-06-27
JP7258870B2 (en) 2023-04-17
PH12020550239A1 (en) 2021-02-15
US20240131134A1 (en) 2024-04-25
CN111225684A (en) 2020-06-02
WO2019075260A1 (en) 2019-04-18
US10835590B2 (en) 2020-11-17
KR102530966B1 (en) 2023-05-15
JP2020536925A (en) 2020-12-17
BR112020006500A2 (en) 2020-10-13
AU2018347511A8 (en) 2020-06-04

Similar Documents

Publication Publication Date Title
GB2582482B (en) CASZ compositions and methods of use
IL263287A (en) Neoepitope vaccine compositions and methods of use thereof
HK1256608A1 (en) Flavonoid compositions and methods of use
GB2582100B (en) CAS12C Compositions and methods of use
IL268970A (en) Novel compositions and methods
HK1248531A1 (en) Immunomodulatory compositions and methods of use thereof
IL269590A (en) Methods and compositions for reduction of immunogenicity
ZA201906169B (en) Synthekine compositions and methods of use
ZA202104969B (en) Compositions comprising 15-hepe and methods of using the same
GB202201861D0 (en) Novel methods and compositions
GB201707211D0 (en) Compositions and methods
ZA202100780B (en) Bismuth-thiol compositions and methods of use
IL276135A (en) Compositions and methods of use
ZA202004531B (en) Compositions containing thymohydroquinone and their method of preparation
IL250853A0 (en) Periodontal gel composition and method of use
GB201801566D0 (en) Methods and compositions for nanormulsion vaccine formulations
ZA202000502B (en) Cosmetic compositions and methods of use
HK1252057A1 (en) Novel method of use and compositions
HK1250345A1 (en) Compositions comprising 15-oxo-epa or 15-oxo-dgla and methods of making and using same
HK1247136A1 (en) Compositions comprising 15-hepe and methods of using the same
IL273690A (en) Periodontitis vaccine and related compositions and method of use
IL250852A0 (en) Periodontal composition and method of use
HK1248527A1 (en) Dental compositions and methods of use
EP3481181A4 (en) Poultry probiotic vaccine compositions and methods of use thereof
IL283703A (en) Polymorphic form of meisoindigo and modified formulation of meisoindigo